Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study to Assess the Effect of a Repeated Dose of XF-73 Nasal Gel on the Microbiological Burden of Commensal Staphylococcus Aureus Nasal Carriage in Surgical Patients at Risk of Post-operative Staphylococcal Infections

NCT03915470 is registered in ClinicalTrials.gov with Destiny Pharma Plc as lead sponsor.

NCT NCT03915470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03915470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study to Assess the Effect of a Repeated Dose of XF-73 Nasal Gel on the Microbiological Burden of Commensal Staphylococcus Aureus Nasal Carriage in Surgical Patients at Risk of Post-operative Staphylococcal Infections
Lead sponsor
Destiny Pharma Plc
Phase
Phase 2
Overall status
Completed
Start date
August 29, 2019
Completion date
March 29, 2021
Enrollment
124 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcal infections, surgical site infection